Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

NCT07028970 is registered in ClinicalTrials.gov with Nanjing IASO Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07028970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07028970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Lead sponsor
Nanjing IASO Biotechnology Co., Ltd.
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2024
Completion date
December 31, 2043
Enrollment
1,500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma